Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

54.09
Delayed Data
As of May 05
 -0.72 / -1.31%
Today’s Change
45.69
Today|||52-Week Range
61.70
+2.40%
Year-to-Date

Today’s Trading

Previous close54.81
Today’s open54.28
Day’s range53.34 - 54.40
Volume11,225,224
Average volume (3 months)10,399,259
Market cap$151.8B
Dividend yield3.40%
Data as of 4:00pm ET, 05/05/2016

Growth & Valuation

Earnings growth (last year)-61.67%
Earnings growth (this year)+3.35%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)-7.92%
P/E ratio34.6
Price/Sales3.87
Price/Book3.41

Competitors

 Today’s
change
Today’s
% change
AGNPRAAllergan plc-11.56-1.44%
NVSNovartis-0.21-0.28%
BMYBristol-Myers Squibb+0.37+0.52%
NVONovo Nordisk-0.25-0.46%
Data as of 4:02pm ET, 05/05/2016

Financials

Next reporting dateJuly 26, 2016
EPS forecast (this quarter)$0.90
Annual revenue (last year)$38.8B
Annual profit (last year)$4.4B
Net profit margin11.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts

Partner Offers

Search for Jobs